About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
SELLAS Life Sciences Initiates Pediatric AML Patient Dosing in Phase 2 SLS009 Trial
SELLAS Life Sciences announced the first pediatric patient has been dosed in its ongoing Phase 2 trial of SLS009 (tambiciclib) for relapsed/refractory...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
SELLAS Life Sciences Initiates Pediatric AML Patient Dosing in Phase 2 SLS009 Trial